These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 2399387

  • 1. Neoadjuvant chemotherapy for bladder cancer: the MSKCC experience.
    Fair WR, Scher H, Herr H, Morse M, Sogani P, Bosi G, Dershaw D, Reuter V, Curley T.
    Semin Urol; 1990 Aug; 8(3):190-6. PubMed ID: 2399387
    [No Abstract] [Full Text] [Related]

  • 2. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
    Koch MO, Coussens D.
    Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122
    [No Abstract] [Full Text] [Related]

  • 3. Extended experience of neo-adjuvant M-VAC chemotherapy for T1-4 N0 M0 transitional cell carcinoma of the urinary bladder.
    Keating JP, Zincke H, Hahn RG, Morgan WR.
    Prog Clin Biol Res; 1990 Feb; 353():119-27. PubMed ID: 2217409
    [No Abstract] [Full Text] [Related]

  • 4. Bladder-sparing approach in the treatment of invasive bladder cancer.
    Wajsman Z, Marino R, Parsons J, Oblon D, McCarley D.
    Semin Urol; 1990 Aug; 8(3):210-5. PubMed ID: 2119051
    [No Abstract] [Full Text] [Related]

  • 5. Adjuvant chemotherapy for non-organ confined bladder transitional cell carcinoma.
    Abi-Aad AS.
    Acta Urol Belg; 1996 May; 64(2):35-7. PubMed ID: 8701808
    [No Abstract] [Full Text] [Related]

  • 6. Adjunctive adjuvant or neoadjuvant chemotherapy for locally advanced bladder cancer: a critical appraisal of the present status.
    Walther PJ.
    Semin Urol; 1993 Nov; 11(4):227-34. PubMed ID: 8290828
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors.
    Angulo JC, Sanchez-Chapado M, Lopez JI, Flores N.
    J Urol; 1996 Jun; 155(6):1897-902. PubMed ID: 8618282
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Neoadjuvant chemotherapy with MVC (methotrexate, vinblastine, cisplatin)in the treatment of infiltrating transitional carcinoma of the bladder].
    Campo B, Torelli T, Leidi GL, Corrada P, Bacchioni AM, Ordesi G, Zanitzer L.
    Arch Ital Urol Nefrol Androl; 1990 Jun; 62(2):237-42. PubMed ID: 2142807
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Systemic chemotherapy in advanced bladder cancer. New aspects].
    Jakse G.
    Wien Klin Wochenschr; 1987 Jan 23; 99(2):54-7. PubMed ID: 3564487
    [Abstract] [Full Text] [Related]

  • 15. Transurethral resection in regionally advanced bladder cancer.
    Herr HW.
    Urol Clin North Am; 1992 Nov 23; 19(4):695-700. PubMed ID: 1441026
    [Abstract] [Full Text] [Related]

  • 16. The cisplatin-methotrexate neo-adjuvant protocol as first-line therapy of bladder cancer. Present experience in Palermo.
    Ingargiola GB, Lamartina M, Cassata G, Corselli G, Serretta V, Caramia G, Rizzo FP, Pavone-Maculuso M.
    Prog Clin Biol Res; 1988 Nov 23; 260():579-83. PubMed ID: 3362907
    [No Abstract] [Full Text] [Related]

  • 17. Adjuvant methotrexate, vinblastine and cisplatin chemotherapy for invasive transitional cell carcinoma: Taiwan experience.
    Wei CH, Hsieh RK, Chiou TJ, Chen KK, Chang LS, Chen PM.
    J Urol; 1996 Jan 23; 155(1):118-21. PubMed ID: 7490806
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Study of the prediction system for clinical response to M-VAC neoadjuvant chemotherapy for bladder cancer.
    Takata R, Obara W, Fujioka T.
    Aktuelle Urol; 2010 Jan 23; 41 Suppl 1():S41-5. PubMed ID: 20094952
    [Abstract] [Full Text] [Related]

  • 20. Preoperative chemotherapy in T3-T4 Nx Mo bladder cancer with cisplatinum and methotrexate.
    Denis L, Da Silva FC, Hendrickx L.
    Prog Clin Biol Res; 1988 Jan 23; 260():571-7. PubMed ID: 3362906
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.